Insmed Inc. buy Wells Fargo & Company
Start price
19.02.25
/
50%
€78.00
Target price
19.02.26
€102.54
Performance (%)
92.31%
Price
23.12.25
€147.00
Summary
This prediction is currently active. With a performance of 92.31% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 19.02.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -10.909% | -10.909% |
| iShares Core DAX® | 0.765% | 4.791% |
| iShares Nasdaq 100 | 1.418% | 3.133% |
| iShares Nikkei 225® | 0.658% | 0.972% |
| iShares S&P 500 | 1.310% | 2.279% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat